NCT01292772

Brief Summary

The primary objective of this study is to use LR imaging to evaluate the effects of adjuvant radiation therapy on reconstructed breasts.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Dec 2010

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2010

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 1, 2011

Completed
9 days until next milestone

First Posted

Study publicly available on registry

February 10, 2011

Completed
5.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2016

Completed
2.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 5, 2019

Completed
Last Updated

April 8, 2020

Status Verified

April 1, 2020

Enrollment Period

6 years

First QC Date

February 1, 2011

Last Update Submit

April 7, 2020

Conditions

Keywords

breast cancerbilateral mastectomyimmediate breast reconstructionlocally advanced unilateral breast cancerbilateral mastectomy for prophylaxis

Outcome Measures

Primary Outcomes (3)

  • Reconstructed Breast Volume

    This will be compared at 2 points: before radiation and 1 year after radiation is completed between the 2 breasts.

    up to 1 year after radiation

  • Vascular Fibrosis

    This will be compared at 2 points: before radiation and 1 year after radiation is completed between the 2 breasts.

    up to 1 year after radiation

  • Dermal Thickness

    This will be compared at 2 pionts: before radiation and 1 year after radiation is completed between the 2 breasts

    up to 1 year after radiation

Secondary Outcomes (6)

  • Presence of Fat Necrosis in the Breast

    up to 1 year after radiation

  • Evidence of Cancer Recurrence

    up to 1 year after radiation

  • Symmetry

    up to 1 year after radiation

  • Hyperpigmentation

    up to 1 year after radiation

  • Contracture

    up to 1 year after radiation

  • +1 more secondary outcomes

Interventions

Patients will have contrast-enhanced MRI of the breasts.

The study group will consist breasts receiving post-operative radiation, and the control group will consist of the patient's breasts on the non-radiated side. In this way, patients will act as their own control.

Eligibility Criteria

Age18 Years - 90 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The target population will consist of patients with a diagnosis of unilateral breast cancer who elect to undero bilateral mastectomy with immediate free flap reconstruction. Patients will be treated by members of the Division of Plastic and Reconstructive Surgery and will receive postoperative radiation therapy to the affected breast.

You may qualify if:

  • Female patients between 18 and 90 years of age.
  • Patients with a diagnosis of unilateral breast cancer who elect to undergo bilateral mastectomy with immediate free flap reconstruction.
  • Patients must also have a locally advanced tumor that requires adjuvant radiation therapy following reconstruction.

You may not qualify if:

  • Women who do not undergo immediate, bilateral breast reconstruction using a free flap.
  • Women who do not require unilateral, adjuvant radiation therapy
  • Women who are pregnant
  • Women who have altered renal function, defined as a personal history of diabetic, hypertensive or autoimmune nephropathy and/or on routine preoperative testing are found to have a serum creatinine greater than or equal to 1.3

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Abramson Cancer Center of the University of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States

Location

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 1, 2011

First Posted

February 10, 2011

Study Start

December 1, 2010

Primary Completion

December 1, 2016

Study Completion

May 5, 2019

Last Updated

April 8, 2020

Record last verified: 2020-04

Locations